Kendle

Kendle is a leading global clinical research organization, delivering innovative and robust clinical development solutions to biopharmaceutical companies. The company has expertise in Phase I-IV spanning 90 countries.

Kendle was recognized by FORTUNE magazine as one of the 100 fastest-growing companies in the United States for 2008. Kendle was named "Top CRO to Work With" in the Thomson CenterWatch 2007 survey of U.S. investigative sites and "Best CRO" for 2007 and 2006 by leading global pharmaceutical publication Scrip World Pharmaceutical News.

Kendle currently has 48 office locations in 28 countries on six continents.

Major service

Clinical Development (Phases I to III)
Regulatory Affairs (Consulting and submission services, pharmacovigilance/safety)
Biometrics (Clinical data management, biostatistics and scientific programming)
Late Phase (Phase IIIB/IV, health economics and outcomes, scientific events, education and publications)


Vision

To be the best-in-class provider of clinical development services to the biopharmaceutical industry through broad therapeutic and geographic expertise.